Combining imaging and gene analysis could transform breast cancer diagnosis

October 25, 2012
Combining imaging and gene analysis could transform breast cancer diagnosis

Combining two approaches - one that digitally scans images of tumour samples and another that analyses genetic information - gives a more accurate prediction of how breast cancer will behave. The research is published today in Science Translational Medicine.

Researchers at the Cancer Research UK Cambridge Research Institute have built a computer system that automatically analyses microscopy images of hundreds of samples. The new approach looks at the makeup of the cells within a tumour, normally undertaken by a pathologist looking down a microscope, and combines these images with the key that are crucial for the development of breast cancer.

Compared to carrying out these tests individually, the new system was more accurate and could give researchers more detailed information about a woman's breast cancer.

Survival from a type of breast cancer called oestrogen receptor negative can be predicted by the number of white blood that have entered the tumour. The increased the accuracy of predictions based on this from 67 to 86 per cent.

The researchers also found a new way to predict survival based on the arrangement of supporting cells within the cancer. Known as the , these cells play a role in encouraging the growth of breast cancers and are not detected in current tests.

Dr Florian Markowetz, the lead researcher at Cancer Research UK's Cambridge Research Institute, said: "Cancers are a mix of different cells – not just – they also include those from the immune system and others that support the structure of the tumour. These cells play an important role in how cancers behave, but this information is not currently detected in tests that focus on the genetic makeup of the cancer.

"By bridging the gap between the 'two cultures' of pathology and genomics our research has a huge potential for better understanding breast cancer."

Professor Carlos Caldas, also based at Cancer Research UK's Cambridge Research Institute, said: "This research complements our study earlier this year that found breast cancer was in fact at least ten different diseases. This now takes us a step closer to being able to use this knowledge in the clinic and directly benefit women with breast cancer."

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: "Combining the visual information from a breast tumour with knowledge of its using computer systems could have a profound impact on how cancer clinics of the future work, enabling doctors to offer women treatments that are tailored to their individual breast cancer."

Explore further: Discovery of protein that fuels breast cancer growth could lead to targeted treatment

More information: Yuan, Y et al Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling (2012) Science Translational Medicine.

Related Stories

Discovery of protein that fuels breast cancer growth could lead to targeted treatment

September 12, 2012
(Medical Xpress)—Cancer Research UK scientists have discovered how a key protein fuels breast cancer growth by boosting numbers of cancer stem cells in tumours that have low levels of a protein called claudin, accounting ...

A simple blood test could be used to detect breast cancer

October 1, 2012
A simple blood test could one day be a more accurate way to test for the early signs of breast cancer than using mammograms to spot a lump say researchers today, as Breast Cancer Awareness Month gets underway.

Beta Blockers could stop breast cancer spreading

September 30, 2011
(Medical Xpress) -- Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast ...

Scientists find new breast cancer genes, rewrite rulebook

April 18, 2012
Scientists at the BC Cancer Agency and University of British Columbia have identified new breast cancer genes that could change the way the disease is diagnosed and form the basis of next-generation treatments.

Gene silencing paves way to new treatments for breast cancer

October 21, 2011
(Medical Xpress) -- Cancer Research UK scientists have discovered that switching off a gene called CERT makes breast cancer cells more sensitive to a range of drugs. The research is published in the Journal of Pathology.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.